Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mayne Pharma Group Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Mayne Pharma Group Ltd (MYX-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 11 $25.00

Mayne Pharma Group Limited (MYX) - Financial Analysis Review

Mayne Pharma Group Limited (MYX) - Financial Analysis Review Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceu...

19 Apr 2016 GlobalData 60 $300.00

Wright Investors Service Comprehensive Report for Mayne Pharma Group Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

05 Apr 2016 Wright Reports 55 $75.00

Mayne Pharma Group Ltd: Upgraded to Below Average

01 Apr 2016 Sadif Analytics Prime 3 $10.00

Mayne Pharma Group Limited (MYX) - Financial Analysis Review

Mayne Pharma Group Limited (MYX) - Financial Analysis Review Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceu...

17 Mar 2016 GlobalData 62 $300.00

Is Now the Time to Buy Mayne Pharma Group Ltd?

01 Mar 2016 Sadif Analytics Prime 12 $25.00

Mayne Pharma Group Limited (MYX) - Financial Analysis Review

Mayne Pharma Group Limited (MYX) - Financial Analysis Review Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceu...

15 Dec 2015 GlobalData 70 $300.00

Is Mayne Pharma Group Ltd Worth a Higher Bid?

27 Nov 2015 Sadif Analytics Prime 12 $25.00

Mayne Pharma Group Ltd: Upgraded to Average

10 Sep 2015 Sadif Analytics Prime 3 $10.00